News
SNYNF
87.10
0.00%
0.00
Nektar: Maintaining 'Strong Buy' Rating Due To REZPEG Catalyst, Another Coming
Seeking Alpha · 1d ago
Sanofi Shuts Down Early Cancer Drug Trial, Trimming One Piece of Its Oncology Pipeline
TipRanks · 1d ago
Sanofi Updates Share Capital and Voting Rights as of July 31, 2026
TipRanks · 2d ago
Sanofi price target lowered to EUR 82 from EUR 86 at Morgan Stanley
TipRanks · 4d ago
Recursion Pharmaceuticals: I'm Still Bearish Despite Recent Genentech News
Seeking Alpha · 5d ago
Midday Fly By: Intel announces $15B offering, Meta unveils Muse Glimmer
TipRanks · 5d ago
Sanofi facing shortages of two drugs for Pompe disease, STAT reports
TipRanks · 5d ago
Weekly Report: what happened at SNYNF last week (0803-0807)?
Weekly Report · 5d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Qiagen (QGEN) and Sanofi (OtherSNYNF)
TipRanks · 08/07 06:10
Sanofi: How I Leveraged This Undervalued Dividend Aristocrat
Seeking Alpha · 08/06 10:13
Teva Pharmaceuticals: Continuing To Execute On Its 'Pivot To Growth' Plan
Seeking Alpha · 08/05 20:05
Sanofi Wins EU Nod to Use MenQuadfi in Infants From Six Weeks
TipRanks · 08/04 05:33
Analysts Conflicted on These Healthcare Names: Sanofi (OtherSNYNF), Ligand Pharma (LGND) and Exelixis (EXEL)
TipRanks · 08/03 12:10
Weekly Report: what happened at SNYNF last week (0727-0731)?
Weekly Report · 08/03 09:47
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Guardant Health (GH) and Pfizer (PFE)
TipRanks · 07/31 14:50
Sanofi (SNYNF) Gets a Hold from J.P. Morgan
TipRanks · 07/31 14:47
Regeneron price target raised to $737 from $696 at RBC Capital
TipRanks · 07/31 14:05
Analysts Are Bullish on Top Healthcare Stocks: Neurocrine (NBIX), Sanofi (SNYNF)
TipRanks · 07/31 13:40
Sanofi Publishes 2026 Half-Year Financial Report for Investors
TipRanks · 07/30 14:03
Analysts Offer Insights on Healthcare Companies: MiMedx Group (MDXG), Sanofi (OtherSNYNF) and Align Tech (ALGN)
TipRanks · 07/30 13:10
More
Webull provides a variety of real-time SNYNF stock news. You can receive the latest news about Sanofi FR through multiple platforms. This information may help you make smarter investment decisions.
About SNYNF
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.